The diverse repertoire of antigen receptors required for mammalian immunity is generated in precursor lymphocytes by V(D)J recombination, which fuses random combinations of immunoglobulin (Ig) or T cell receptor (Tcr) gene segments to form a signature variable region exon for each lymphocyte. Although V(D)J recombination is critical for diversification of antigen receptors, reshaping the genome of somatic cells is perilous. Errant targeting of V(D)J recombination produces chromosomal translocations involving proto- oncogenes, which initiate most known leukemias and lymphomas. Moreover, V(D)J recombination must be sequentially activated or repressed at distinct regions within Ig and Tcr loci to orchestrate lymphocyte development. In large part, the tissue-, stage- and allele-specific control of V(D)J recombination is coordinated by genetic elements that alter the accessibility of chromatin at Ig and Tcr loci. The applicant's laboratory has shown that transcriptional promoters and enhancers serve as accessibility control elements (ACEs) to direct the first step of Tcrb gene assembly (D2AEJ2 recombination). Studies in the prior funding period revealed that ACEs mediate a series of biochemical events that culminate in a recombinase-accessible Tcrb locus, including (i) enhancer-directed chromatin opening, (ii) formation of a higher order promoter-enhancer complex, and (iii) promoter-dependent recruitment of chromatin remodeling complexes to unmask neighboring gene segments for recombination. Based on these discoveries, we hypothesize that thymocyte development relies on a sequential recruitment of transcription factors to ACEs within Tcrb, which coordinate a precise epigenetic program leading to regional or highly localized changes in recombinase accessibility. To test this central hypothesis, we will identify TFs that bridge distal ACEs to generate a promoter-enhancer holocomplex (Aim 1).
Aim 2 studies will establish the molecular mechanisms by which chromatin remodeling complexes are recruited to ACEs as well as their subsequent mode of action to confer recombinase accessibility.
Aim 3 studies will follow, in real-time, the contingent mechanisms that control stepwise opening of Tcrb to recombinase.
In Aim 4, we will define epigenetic changes in nucleosome composition and histone modifications that protect specific gene segments from the long-range ACE function of enhancers and subsequently unlock these segments for recombination. Overall, the project will establish the genetic, epigenetic, and topological mechanisms by which V(D)J recombinase is permitted access to specific gene segments, resulting in a fully functional immune repertoire. The research will also provide insights into processes that control chromatin accessibility during transcription, replication, and recombination of select genomic information in all eukaryotic cells. Public Health Relevance: Developing lymphocytes cut-and-paste together an enormous collection of antigen receptor genes by the process of V(D)J recombination. This unique process of DNA recombination must be tightly regulated in precursor cells to guide their development into functional, mature lymphocytes and to preclude chromosomal translocations that lead to lymphoid tumors. We propose studies to address how precursor T lymphocytes activate the T cell receptor beta locus at the earliest stages of thymocyte development to ensure its proper assembly by V(D)J recombination.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI079732-07
Application #
7867077
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Nasseri, M Faraz
Project Start
2003-04-01
Project End
2013-11-30
Budget Start
2009-06-01
Budget End
2009-11-30
Support Year
7
Fiscal Year
2009
Total Cost
$174,800
Indirect Cost
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Majumder, Kinjal; Rupp, Levi J; Yang-Iott, Katherine S et al. (2015) Domain-Specific and Stage-Intrinsic Changes in Tcrb Conformation during Thymocyte Development. J Immunol 195:1262-72
Majumder, Kinjal; Koues, Olivia I; Chan, Elizabeth A W et al. (2015) Lineage-specific compaction of Tcrb requires a chromatin barrier to protect the function of a long-range tethering element. J Exp Med 212:107-20
Collins, Patrick L; Kyle, Katherine E; Egawa, Takeshi et al. (2015) The histone methyltransferase SETDB1 represses endogenous and exogenous retroviruses in B lymphocytes. Proc Natl Acad Sci U S A 112:8367-72
Dorsett, Yair; Zhou, Yanjiao; Tubbs, Anthony T et al. (2014) HCoDES reveals chromosomal DNA end structures with single-nucleotide resolution. Mol Cell 56:808-18
Predeus, Alexander V; Gopalakrishnan, Suhasni; Huang, Yue et al. (2014) Targeted chromatin profiling reveals novel enhancers in Ig H and Ig L chain Loci. J Immunol 192:1064-70
Reed, N P; Henderson, M A; Oltz, E M et al. (2013) Reciprocal regulation of Rag expression in thymocytes by the zinc-finger proteins, Zfp608 and Zfp609. Genes Immun 14:7-12
Gopalakrishnan, Suhasni; Majumder, Kinjal; Predeus, Alexander et al. (2013) Unifying model for molecular determinants of the preselection V? repertoire. Proc Natl Acad Sci U S A 110:E3206-15
Collins, Patrick L; Oltz, Eugene M (2013) Histone methylation keeps the brakes on autophagy. Mol Cell Biol 33:3974-5
Kondilis-Mangum, Hrisavgi D; Cobb, Robin Milley; Osipovich, Oleg et al. (2010) Transcription-dependent mobilization of nucleosomes at accessible TCR gene segments in vivo. J Immunol 184:6970-7
Ji, Yanhong; Little, Alicia J; Banerjee, Joydeep K et al. (2010) Promoters, enhancers, and transcription target RAG1 binding during V(D)J recombination. J Exp Med 207:2809-16

Showing the most recent 10 out of 12 publications